All articles tagged with #gliomas
A novel vaccine targeting the IDH1 mutation in gliomas, a deadly type of brain tumor, has shown promising results in clinical trials by mobilizing the immune system to attack cancer cells with precision. This breakthrough in immunotherapy, led by Michael Platten, has been recognized with the "Breakthrough of the Year 2024" award, highlighting its potential to revolutionize cancer treatment beyond brain tumors.
Researchers have developed a tiny device, the size of a grain of rice, that can simultaneously test the effects of up to 20 drugs on brain tumors during surgery. The device, implanted into the tumor and removed afterward, provides real-time insights on drug effects on the tumor microenvironment, offering a more personalized approach to treating challenging brain cancers like gliomas. The device has shown promising results in a pilot clinical trial, with no adverse effects reported.
An AI tool called Charm has been developed to assist surgeons in identifying the genetic profile of gliomas, a type of aggressive brain tumor, during surgery. While its accuracy may not match current genetic tests, Charm can swiftly predict a tumor's profile, allowing doctors to proceed with appropriate treatment without the need for additional surgeries. The tool can also distinguish between malignant and benign tumor cells and determine the tumor's grade, potentially eliminating the need for a pathologist during the operation. This advancement in AI technology contributes to the broader use of AI in enhancing cancer diagnosis and treatment.